AbCellera Biologics Inc. (ABCL)

AbCellera Biologics Statistics

Total Valuation

ABCL has a market cap or net worth of $884.62 million. The enterprise value is $323.22 million.

Market Cap	884.62M
Enterprise Value	323.22M

Important Dates

The last earnings date was Monday, November 4, 2024, after market close.

Earnings Date	Nov 4, 2024
Ex-Dividend Date	n/a

Share Statistics

ABCL has 295.37 million shares outstanding. The number of shares has increased by 1.70% in one year.

Current Share Class	295.37M
Shares Outstanding	295.37M
Shares Change (YoY)	+1.70%
Shares Change (QoQ)	+0.22%
Owned by Insiders (%)	26.63%
Owned by Institutions (%)	30.49%
Float	189.20M

Valuation Ratios

PE Ratio	n/a
Forward PE	n/a
PS Ratio	26.94
Forward PS	19.59
PB Ratio	0.83
P/TBV Ratio	0.92
P/FCF Ratio	n/a
P/OCF Ratio	n/a
PEG Ratio	n/a

Enterprise Valuation

EV / Earnings	n/a
EV / Sales	9.81
EV / EBITDA	n/a
EV / EBIT	n/a
EV / FCF	n/a

Financial Position

The company has a current ratio of 9.34, with a Debt / Equity ratio of 0.07.

Current Ratio	9.34
Quick Ratio	8.88
Debt / Equity	0.07
Debt / EBITDA	n/a
Debt / FCF	n/a
Interest Coverage	n/a

Financial Efficiency

Return on equity (ROE) is -15.55% and return on invested capital (ROIC) is -15.96%.

Return on Equity (ROE)	-15.55%
Return on Assets (ROA)	-13.26%
Return on Capital (ROIC)	-15.96%
Revenue Per Employee	$56,249
Profits Per Employee	-$299,995
Employee Count	586
Asset Turnover	0.02
Inventory Turnover	n/a

Taxes

Income Tax	-26.37M
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has decreased by -38.10% in the last 52 weeks. The beta is 0.41, so ABCL's price volatility has been lower than the market average.

Beta (5Y)	0.41
52-Week Price Change	-38.10%
50-Day Moving Average	2.72
200-Day Moving Average	3.37
Relative Strength Index (RSI)	57.48
Average Volume (20 Days)	2,694,614

Short Selling Information

The latest short interest is 15.93 million, so 5.39% of the outstanding shares have been sold short.

Short Interest	15.93M
Short Previous Month	16.64M
Short % of Shares Out	5.39%
Short % of Float	8.42%
Short Ratio (days to cover)	6.39

Income Statement

In the last 12 months, ABCL had revenue of $32.96 million and -$175.80 million in losses. Loss per share was -$0.61.

Revenue	32.96M
Gross Profit	-136.84M
Operating Income	-308.06M
Pretax Income	-178.81M
Net Income	-175.80M
EBITDA	-222.24M
EBIT	-308.06M
Loss Per Share	-$0.61

Balance Sheet

The company has $643.14 million in cash and $71.40 million in debt, giving a net cash position of $571.74 million or $1.94 per share.

Cash & Cash Equivalents	643.14M
Total Debt	71.40M
Net Cash	571.74M
Net Cash Per Share	$1.94
Equity (Book Value)	1.08B
Book Value Per Share	3.65
Working Capital	663.32M

Cash Flow

In the last 12 months, operating cash flow was -$120.17 million and capital expenditures -$77.20 million, giving a free cash flow of -$197.36 million.

Operating Cash Flow	-120.17M
Capital Expenditures	-77.20M
Free Cash Flow	-197.36M
FCF Per Share	-$0.67

Margins

Gross Margin	n/a
Operating Margin	-934.60%
Pretax Margin	-613.34%
Profit Margin	n/a
EBITDA Margin	n/a
EBIT Margin	n/a
FCF Margin	-515.51%

Dividends & Yields

ABCL does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	-1.70%
Shareholder Yield	-1.70%
Earnings Yield	-19.64%
FCF Yield	-22.05%

Analyst Forecast

The average price target for ABCL is $8.50, which is 183.81% higher than the current price. The consensus rating is "Buy".

Price Target	$8.50
Price Target Difference	183.81%
Analyst Consensus	Buy
Analyst Count	3
Revenue Growth Forecast (5Y)	20.33%
EPS Growth Forecast (5Y)	n/a

Stock Splits

This stock does not have any record of stock splits.

Last Split Date	n/a
Split Type	n/a
Split Ratio	n/a

Scores

ABCL has an Altman Z-Score of 2.28 and a Piotroski F-Score of 2. A Z-score under 3 suggests an increased risk of bankruptcy.

Altman Z-Score	2.28
Piotroski F-Score	2